ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,629.00
0.00%
S&P ASX All Technology
3,016.30
0.00%
Brent Oil
83.245
0.58%
US Dollar vs AUD
1.51226
-0.12%
Bitcoin
63,855.71
-0.06%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. AlloVir Inc (ALVR)

  7. AlloVir Inc (ALVR) News

ALVR

AlloVir (ALVR)

AlloVir Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ALVR
DateTimeSourceHeadlineSymbolCompany
14/03/202421:10PR Newswire (US)Class Action Filed Against AlloVir, Inc. (ALVR) Seeking Recovery for Investors - Contact The Gross Law FirmNASDAQ:ALVRAlloVir Inc
07/03/202421:45PR Newswire (US)The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 19, 2024 in AlloVir, Inc. Lawsuit - ALVRNASDAQ:ALVRAlloVir Inc
23/02/202408:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALVRAlloVir Inc
22/02/202421:45PR Newswire (US)Class Action Filed Against AlloVir, Inc. (ALVR) Seeking Recovery for Investors - Contact The Gross Law FirmNASDAQ:ALVRAlloVir Inc
22/02/202412:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALVRAlloVir Inc
21/02/202409:00Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALVRAlloVir Inc
16/02/202408:30Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:ALVRAlloVir Inc
13/02/202408:34Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALVRAlloVir Inc
09/02/202421:45PR Newswire (US)Shareholders that lost money on AlloVir, Inc.(ALVR) Urged to Join Class Action - Contact The Gross Law Firm to Learn MoreNASDAQ:ALVRAlloVir Inc
07/02/202408:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALVRAlloVir Inc
06/02/202412:00Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALVRAlloVir Inc
02/02/202421:45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of AlloVir, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 19, 2024 - (NASDAQ: ALVR)NASDAQ:ALVRAlloVir Inc
26/01/202421:45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of AlloVir, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 19, 2024 - (NASDAQ: ALVR)NASDAQ:ALVRAlloVir Inc
26/01/202408:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALVRAlloVir Inc
24/01/202412:30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALVRAlloVir Inc
10/01/202404:32Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ALVRAlloVir Inc
10/01/202404:29Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ALVRAlloVir Inc
09/01/202408:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALVRAlloVir Inc
05/01/202422:14IH Market NewsWall Street Highlights: Google Rejects Union Negotiations, Exxon Mobil Announces $2.5 Billion Accounting Write-Down in CaliforniaNASDAQ:ALVRAlloVir Inc
05/01/202410:00Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALVRAlloVir Inc
05/01/202409:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALVRAlloVir Inc
22/12/202323:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALVRAlloVir Inc
22/12/202323:00GlobeNewswire Inc.AlloVir Provides Updates on Phase 3 Clinical Development Program for Posoleucel, an Allogeneic Virus-Specific T Cell TherapyNASDAQ:ALVRAlloVir Inc
22/11/202309:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALVRAlloVir Inc
21/11/202309:00Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALVRAlloVir Inc
18/11/202309:30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALVRAlloVir Inc
16/11/202323:00Business WireAlloVir to Present at the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:ALVRAlloVir Inc
03/11/202307:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ALVRAlloVir Inc
02/11/202323:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALVRAlloVir Inc
02/11/202322:00Business WireAlloVir Reports Third Quarter 2023 Financial ResultsNASDAQ:ALVRAlloVir Inc
 Showing the most relevant articles for your search:NASDAQ:ALVR

Your Recent History

NASDAQ
AAPL
Apple
FX
AUDCAD
AUD vs CAD
ASX
MQG
Macquarie
ASX
XJO
S&P ASX 200
CCOM
SILVER
SILVER
NYSE
VZ
Verizon Communications
NYSE
XOM
Exxon Mobil
NYSE
DIS
Walt Disney
ASX
ANZ
Australia And New Zealan...
ASX
NAB
National Australia Bank
FX
AUDUSD
AUD vs US Dollar
ASX
WDC
Westfield
ASX
BHP
BHP
ASX
TLS
Telstra
ASX
AMP
AMP
NASDAQ
NVDA
NVIDIA
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved